Market Snapshot
S&P Futures
4,122
Dow Futures
32,740
Nasdaq Futures
12,989.5
Evofem Biosciences, Inc. (EVFM) stock declined over -5.49% intraday to trade at $0.7562 a share on NASDAQ. The stock opened with a loss of -27.98% at $0.921 and touched an intraday high of $0.926, falling -19.81% against the last close of $0.943. The stock went to a low of $0.79 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $0.921 | $0.926 | $0.79 | $0.8 | 18,101,536 |
2022-08-05 | $1.05 | $1.11 | $0.901 | $0.943 | 39,006,000 |
2022-08-04 | $0.881 | $0.93 | $0.82 | $0.898 | 26,977,600 |
2022-08-03 | $0.762 | $0.91 | $0.762 | $0.87 | 16,660,300 |
2022-08-02 | $0.739 | $0.81 | $0.721 | $0.765 | 7,417,000 |
2022-08-01 | $0.73 | $0.795 | $0.715 | $0.77 | 8,079,500 |
2022-07-29 | $0.855 | $0.87 | $0.723 | $0.73 | 15,229,100 |
2022-07-28 | $0.753 | $0.769 | $0.69 | $0.74 | 9,301,400 |
2022-07-27 | $0.81 | $0.82 | $0.74 | $0.789 | 10,483,000 |
2022-07-26 | $0.848 | $0.853 | $0.8 | $0.828 | 8,604,000 |
Employees-
Beta-1.56
Sales or Revenue11.39 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Evofem Biosciences, Inc. (NASDAQ: EVFM) stock price is $0.7562 as of the last check on Monday, August 8. During the trading session, EVFM stock reached the peak price of $0.926 while $0.79 was the lowest point it dropped to.
The NASDAQ listed EVFM is part of Pharmaceuticals industry that operates in the broader Health Care sector. Evofem Biosciences, Inc. , a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health.
Ms. Saundra Pelletier
Pres, CEO & Director
Mr. Russell Barrans
Chief Commercial Officer
Dr. Kelly Culwell M.D.
Chief Medical Officer
Ms. Saundra Pelletier
Interim Chair, Pres & CEO
EVFM stock traded closed the last session at $0.8, which is -$0.04390000000000005 or -5.486814148231478% lower than its previous close of $0.943. EVFM's current trading price is 190.95% lower than its 52-week high of $14.61 where as its distance from 52-week low of 0.28% is -94.52%.
Number of EVFM employees currently stands at -. EVFM operates from 12400 High Bluff Drive, Suite 600, San Diego, CA 92130, United States.
Official Webiste of $EVFM is: https://www.evofem.com
EVFM could be contacted at EVFM operates from 12400 High Bluff Drive, Suite 600, San Diego, CA 92130, United States, or at phone #858 550 1900 and can also be accessed through its website.
EVFM stock volume for the day was 3,362,236 shares while in the previous session number of EVFM shares traded was 18,101,536 . The average number of EVFM shares traded daily for last 3 months was 34.23 Million.
The percentage change in EVFM stock occurred in the recent session was -5.486814148231478% while the dollar amount for the price change in EVFM stock was -$0.04390000000000005.
In the recent session, the day high for EVFM stock was $0.926 while the low for EVFM stock touched on the day was $0.79.
The market value of EVFM currently stands at 36.57 Million with its latest stock price at $0.7562 and 45.71 Million of its shares outstanding.